[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Donthamsetti et al., 2017 - Google Patents

Optical control of dopamine receptors using a photoswitchable tethered inverse agonist

Donthamsetti et al., 2017

View PDF
Document ID
10222842776348101999
Author
Donthamsetti P
Winter N
Schönberger M
Levitz J
Stanley C
Javitch J
Isacoff E
Trauner D
Publication year
Publication venue
Journal of the American Chemical Society

External Links

Snippet

Family AG protein-coupled receptors (GPCRs) control diverse biological processes and are of great clinical relevance. Their archetype rhodopsin becomes naturally light sensitive by binding covalently to the photoswitchable tethered ligand (PTL) retinal. Other GPCRs …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)

Similar Documents

Publication Publication Date Title
Donthamsetti et al. Optical control of dopamine receptors using a photoswitchable tethered inverse agonist
Donthamsetti et al. Genetically targeted optical control of an endogenous G protein-coupled receptor
Hansen et al. Synthesis and structure–activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists
Lemoine et al. Optical control of an ion channel gate
Brust et al. Modification of the orthosteric PPARγ covalent antagonist scaffold yields an improved dual-site allosteric inhibitor
Bahamonde et al. Photomodulation of G protein-coupled adenosine receptors by a novel light-switchable ligand
Mundell et al. Desensitization and internalization of metabotropic glutamate receptor 1a following activation of heterologous Gq/11-coupled receptors
Donthamsetti et al. Cell specific photoswitchable agonist for reversible control of endogenous dopamine receptors
Cheng et al. Photoswitchable inhibitor of a glutamate transporter
Gavande et al. Design, synthesis, and pharmacological evaluation of fluorescent and biotinylated antagonists of ρ1 GABAC receptors
Sniecikowska et al. Discovery of novel pERK1/2-or β-arrestin-preferring 5-HT1A receptor-biased agonists: Diversified therapeutic-like versus side effect profile
Cheng et al. A photoswitchable inhibitor of the human serotonin transporter
Bartole et al. UR-DEBa242: a Py-5-labeled fluorescent multipurpose probe for investigations on the histamine H3 and H4 receptors
Lutz et al. Development of new photoswitchable azobenzene based γ-aminobutyric acid (GABA) uptake inhibitors with distinctly enhanced potency upon photoactivation
Ullmann et al. Homobivalent dopamine D2 receptor ligands modulate the dynamic equilibrium of D2 monomers and homo-and heterodimers
Lima Neto et al. Exploring the binding mechanism of GABAB receptor agonists and antagonists through in silico simulations
Fu et al. Genetically encoding quinoline reverses chromophore charge and enables fluorescent protein brightening in acidic vesicles
Ricart-Ortega et al. Mechanistic insights into light-driven allosteric control of GPCR biological activity
Leippe et al. Optical control of a delayed rectifier and a two-pore potassium channel with a photoswitchable bupivacaine
Shashack et al. Synthesis and evaluation of dimeric derivatives of 5-HT2A receptor (5-HT2AR) antagonist M-100907
Qiao et al. Photosensitive and photoswitchable TRPA1 agonists optically control pain through channel desensitization
Kim et al. Developing photoaffinity probes for dopamine receptor D2 to determine targets of Parkinson’s disease drugs
Li et al. Activity-based probe for specific photoaffinity labeling γ-aminobutyric acid B (GABAB) receptors on living cells: design, synthesis, and biological evaluation
Yamamoto et al. Structurally diverse GABA antagonists interact differently with open and closed conformational states of the ρ1 receptor
Lin et al. Light-switchable ion channels and receptors for optogenetic interrogation of neuronal signaling